Dr. Forconi on the Benefits of Combining Venetoclax and Ibrutinib in Treating Chronic Lymphocytic Leukemia (CLL) Dr. Francesco Forconi of the University Of Southampton in the UK has a deep understanding of the nature of CLL... Details
ASH 2017: Anthony Mato on Kinase Inhibitor Intolerance in Chronic Lymphocytic Leukemia (CLL) We know that the leading reason most patients stop taking ibrutinib and other kinase inhibitors (KI) is that they become... Details
ASH 2017: Michael Choi MD Discusses Venetoclax after Failing 2 B-cell receptor (BCR) Inhibitors in Chronic Lymphocytic Leukemia (CLL) We have great new drugs approved and in development to treat CLL that inhibit the B cell receptor (BCRi), such... Details
ASH 2017: Dr. Mato on Real-World Use of Venetoclax for Chronic Lymphocytic Leukemia (CLL) The advantages we are enjoying these days of longer lives and better quality of life is largely the result of... Details
ASH 2017: Dr. Brander on Umbralisib (TGR-1202) in CLL (chronic lymphocytic leukemia) As the former US Surgeon General, Dr. C. Everett Koop, famously said, “Drugs don't work in patients who don't take them.” We... Details
ASH 2017: Dr. Ian Flinn on duvelisib treatment of CLL (chronic lymphocytic leukemia) At the ASH (American Society of Hematology) Annual Conference in Atlanta in December 2017, Dr. Ian Flinn from Sarah Cannon... Details
ASH 2017: Dr. Ian Flinn on venetoclax and obinutuzumab for frontline treatment of CLL (chronic lymphocytic leukemia) At ASH (American Society of Hematology) Annual Conference in Atlanta in December, 2017, Dr. Ian Flinn from Sarah Cannon Cancer... Details
ASH 2017: Dr. John Pagel Discusses Real-world Data on the Use of Venetoclax in CLL By Brian Koffman, MD and John Pagel, MD, PhD At the ASH (American Society of Hematology) Annual Meeting and Exposition... Details
ASH 2017 Atlanta: Dr. Matthew Davids on the Amazing Results of Ibrutinib in Combination with FCR for frontline CLL (chronic lymphocytic leukemia) Combinations of potent medications are the future in CLL. At the American Society of Hematology (ASH) Annual Meeting and Exposition... Details
Day Four ASH 2017 Atlanta, Georgia on CLL (chronic lymphocytic leukemia) Today is only a half-day with a very early start at ASH 2017 in Atlanta, Georgia, then the long trip... Details
